RELMADA THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RELMADA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $150.38M.
- RELMADA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2022-06-30 was $13.15M.
- RELMADA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2022-03-31 was $29.58M.
- RELMADA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $10.24T.
- RELMADA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2025 was $93.64M.
- RELMADA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2022 was -$50.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $150.38M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $93.64M 10-K · filed 2026-03-19 | |
| 2022-12-31 | -$50.00K 10-K · filed 2023-03-23 | |
| 2022-06-30 | $13.15M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $29.58M 10-Q · filed 2023-11-08 | |
| 2021-09-30 | $10.24T 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $19.86M 10-Q · filed 2020-08-12 | |
| 2007-12-31 | $1.11K 8-K · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |